US Stock MarketDetailed Quotes

CVAC CureVac

Watchlist
  • 2.790
  • -0.050-1.76%
Close Nov 11 16:00 ET
  • 2.730
  • -0.060-2.15%
Post 19:58 ET
625.84MMarket Cap-2094P/E (TTM)

CureVac Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CureVac Q3 2024 Estimates Date

Currency：EURNov 12, 2024

Estimate YoY
Revenue
138.33M
+738.35%
EPS
0.42
+292.31%
Analyst Rating
Buy

Nov 11, 2024

CureVac Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 86.106M --
Nov 12, 2024 2024/Q3 -- / 138.328M --
Aug 15, 2024 2024/Q2 14.436M / 4.911M --
May 23, 2024 2024/Q1 12.373M / 12.889M --
Apr 24, 2024 2023/Q4 22.600M / 29.083M --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 86.106M--
Nov 12, 20242024/Q3-- / 138.328M--
Aug 15, 20242024/Q214.436M / 4.911M--
May 23, 20242024/Q112.373M / 12.889M--
Apr 24, 20242023/Q422.600M / 29.083M--

Unlock Free Earnings Estimates

CureVac Earnings Reports

  • CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 16 04:32

  • CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 16 04:27

  • CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

    May 24 04:31

  • CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

    May 24 04:18

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 11, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data